Skip to main content

Table 6 Identification of amino acid substitutions in H3 antigenic sites of H3N2 viruses. Antigenic sites of H3 protein were compared to vaccine strains Brisbane/2007. Here, we are presenting changes in antigenic sites of viruses isolated following any modification in H3N2 vaccine strain (2012, 2014, 2015, 2016 and 2017). Dash (−) indicates amino acid similar to vaccine sequence while amino acids different than vaccine strain are indicated in italics. Bold amino acids denote amino acid changes found in vaccine strains recommended for subsequent season in comparison to Brisbane/2007. Similarity of antigenic sites between vaccine strain and circulating viruses is shown as percentages in the last column

From: Epidemiological and genetic characterization of pH1N1 and H3N2 influenza viruses circulated in MENA region during 2009–2017

H3

Similarity to vaccine strains (%)

 

A1

A2

A3

B1

B2

C1

C2

E1

D

 
 

121

135

142

144

145

157

158

159

160

189

194

53

278

62

212

215

Brisbane/2007

N

T

R

N

N

L

K

F

K

N

L

D

N

E

T

P

A

B

C

E

D

2009

K

N

K

A

100

89.5

100

100

97

Perth/2009

N

T

R

K

N

L

N

F

K

K

L

D

N

K

T

S

 

2012

K

N

N

S

D

A

P

A

P

90

100

84

100

88

Victoria/2011

N

T

R

N

N

L

N

F

K

K

L

D

N

E

A

P

 

2014

G

S

L

S

F

Y

S

90

89.5

84

100

100

Texas/2012

N

T

R

N

N

L

N

F

K

K

L

D

K

E

A

P

 

2015

R

G

S

S

Y

T

86.3

89.5

100

100

100

Switzerland/2013

N

T

G

N

S

L

N

S

K

K

L

D

K

E

A

P

 

2016

N

K

G

R

S

K

F

Y

N

K

N

82

89.5

66.6

100

100

Hong Kong/2014

N

T

R

S

S

L

N

Y

K

K

P

D

K

E

A

P

 

2017

K

K

R

G

S

K

T

L

77

89.5

100

100

100